Nejat K Egilmez Selected Research

Microspheres (Microsphere)

1/2023	Microencapsulated IL-12 Drives Genital Tract Immune Responses to Intranasal Gonococcal Outer Membrane Vesicle Vaccine and Induces Resistance to Vaginal Infection with Diverse Strains of Neisseria gonorrhoeae.
10/2020	Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma.
10/2019	Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment.
1/2018	Intravaginal Administration of Interleukin 12 during Genital Gonococcal Infection in Mice Induces Immunity to Heterologous Strains of Neisseria gonorrhoeae.
8/2015	Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease.
12/2013	Enhancement of adaptive immunity to Neisseria gonorrhoeae by local intravaginal administration of microencapsulated interleukin 12.
6/2011	Nitric oxide short-circuits interleukin-12-mediated tumor regression.
12/2007	Controlled-release particulate cytokine adjuvants for cancer therapy.
11/2006	Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
6/2006	Chronic immune therapy induces a progressive increase in intratumoral T suppressor activity and a concurrent loss of tumor-specific CD8+ T effectors in her-2/neu transgenic mice bearing advanced spontaneous tumors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nejat K Egilmez Research Topics

Disease

47	Neoplasms (Cancer) 04/2023 - 04/2002
6	Neoplasm Metastasis (Metastasis) 10/2019 - 01/2003
5	Colitis 01/2022 - 06/2015
4	Infections 01/2023 - 12/2013
4	Inflammation (Inflammations) 01/2023 - 07/2015
4	Colonic Neoplasms (Colon Cancer) 01/2021 - 04/2015
4	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2004
3	Lung Neoplasms (Lung Cancer) 04/2023 - 05/2002
3	Gonorrhea 01/2023 - 12/2013
3	Obesity 10/2021 - 11/2018
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 08/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2020
2	Adenocarcinoma 10/2020 - 10/2019
2	Carcinogenesis 11/2018 - 01/2017
2	Reinfection 01/2018 - 12/2013
2	Schistosomiasis (Bilharziasis) 01/2015 - 05/2004
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Alopecia (Baldness) 12/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021
1	Intestinal Polyps 01/2021
1	Dysbiosis 01/2020
1	Reproductive Tract Infections 01/2018
1	Weight Loss (Weight Reduction) 08/2015
1	Polyps 07/2015
1	Pathologic Complete Response 05/2014
1	Communicable Diseases (Infectious Diseases) 12/2013

Drug/Important Bio-Agent (IBA)

26	Interleukin-12 (IL 12)IBA 01/2023 - 05/2002
13	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016 - 12/2002
12	CytokinesIBA 01/2023 - 05/2002
6	AntibodiesIBA 01/2023 - 10/2005
6	Interleukin-10 (Interleukin 10)IBA 11/2018 - 06/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 12/2013
4	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 02/2007
3	VaccinesIBA 01/2023 - 12/2013
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2005
3	Fatty Acid-Binding ProteinsIBA 12/2022 - 01/2018
3	EnzymesIBA 01/2020 - 12/2002
3	Interferon-gamma (Interferon, gamma)IBA 01/2018 - 05/2002
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018 - 08/2015
3	Immunoglobulin G (IgG)IBA 01/2018 - 12/2013
3	PolymersIBA 12/2013 - 12/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2007 - 02/2004
2	Interleukin-17 (Interleukin 17)IBA 01/2023 - 06/2021
2	Fish OilsIBA 12/2022 - 01/2020
2	Anthocyanins (Anthocyanin)IBA 01/2021 - 01/2020
2	Immunoglobulin A (IgA)IBA 01/2018 - 12/2013
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 08/2015 - 01/2004
2	ChemokinesIBA 06/2015 - 01/2003
2	SuspensionsIBA 07/2012 - 02/2004
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2012 - 10/2011
1	Interleukin-17 ReceptorsIBA 01/2023
1	Blocking AntibodiesIBA 01/2023
1	fibroblast growth factor 21IBA 01/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	Phospholipases A2 (Phospholipase A2)IBA 01/2022
1	Unsaturated Dietary FatsIBA 10/2021
1	Dietary Fats (Dietary Fat)IBA 10/2021
1	OilsIBA 10/2021
1	Linoleic AcidsIBA 10/2021
1	Immune Checkpoint InhibitorsIBA 06/2021
1	Therapeutic UsesIBA 01/2021
1	cocoa butterIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	LigandsIBA 01/2019
1	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 01/2019
1	Delayed-Action PreparationsIBA 01/2017
1	hemoglobin P (Hb P)IBA 01/2017
1	SodiumIBA 08/2015
1	Dextrans (Dextran)FDA Link 08/2015
1	AntigensIBA 07/2015
1	Dextran SulfateIBA 06/2015
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2015
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 04/2015
1	Praziquantel (Biltricide)FDA Link 01/2015
1	AntioxidantsIBA 01/2015
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2011
1	arginine methyl esterIBA 06/2011
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 06/2011
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2010
1	Tryptophan (L-Tryptophan)FDA Link 01/2010
1	Interleukin-15 (Interleukin 15)IBA 08/2009
1	Bromodeoxyuridine (BrdU)IBA 04/2009

Therapy/Procedure

18	Therapeutics 04/2023 - 04/2002
15	Microspheres (Microsphere) 01/2023 - 12/2002
8	Immunotherapy 10/2020 - 12/2002
3	Aftercare (After-Treatment) 01/2010 - 02/2004
2	Radiotherapy 10/2019 - 05/2014
2	Neoadjuvant Therapy 10/2019 - 12/2002
2	Injections 12/2004 - 12/2002
1	Chemoprevention 01/2020
1	Intravaginal Administration 01/2018
1	Precision Medicine 06/2015
1	Drug Therapy (Chemotherapy) 01/2015